GlassScriptPhysician profile
Syed S Ali
NPI 1578787339
$14,923.77
in general payments reported to CMS, 2019-2025
43 companies · $2,730 in 2025
The $2,730 reported for 2025 was more than what 87% of Cardiovascular Disease providers received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,833 · 2020: $1,254 · 2021: $1,498 · 2022: $3,497 · 2023: $2,371 · 2024: $1,740 · 2025: $2,730.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,652 · Travel and Lodging: $2,190.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,651.72 |
| Travel and Lodging | $2,189.98 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $2,370.29 | 2020-2025 | Triclip, Optis, Ensite |
| Medtronic, INC. | $1,718.86 | 2022-2025 | Onyx Frontier, Euphora, Launcher |
| Boston Scientific Corporation | $1,637.85 | 2021-2025 | Watchman Flx |
| Janssen Pharmaceuticals, INC | $1,177.63 | 2019-2024 | Xarelto |
| Astrazeneca Pharmaceuticals LP | $808.13 | 2019-2025 | Farxiga, Lokelma, Wainua |
| Boehringer Ingelheim Pharmaceuticals, INC. | $793.61 | 2019-2024 | Jardiance |
| Amgen INC. | $656.18 | 2019-2025 | Repatha, Repatha |
| Pfizer INC. | $645.82 | 2019-2025 | |
| Atricure, INC. | $602.87 | 2019-2025 | Synergy Ablation System |
| Novartis Pharmaceuticals Corporation | $548.81 | 2019-2025 | |
| Shockwave Medical, INC | $434.87 | 2022-2024 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Esperion Therapeutics, INC. | $299.04 | 2020-2024 | Nexletol |
| Amarin Pharma, INC. | $277.81 | 2019-2022 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $232.85 | 2019-2022 | |
| E.R. Squibb & Sons, L.L.C. | $216.42 | 2019-2025 | Eliquis, Camzyos |
Show all 43 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Smith+Nephew, INC. | $214.28 | 2020-2021 | |
| Kestra Medical Technology Services, INC. | $207.25 | 2023-2024 | Assure Wcd |
| Janssen Scientific Affairs, LLC | $204.36 | 2019-2022 | |
| Merck Sharp & Dohme LLC | $179.89 | 2021-2023 | Verquvo |
| Novo Nordisk INC | $176.12 | 2024-2025 | Wegovy, Ozempic, Rybelsus |
| Abiomed | $156.29 | 2019-2025 | |
| Alnylam Pharmaceuticals INC. | $155.61 | 2022-2025 | Onpattro |
| Sanofi-Aventis U.S. LLC | $145.81 | 2019 | |
| Medtronic Vascular, INC. | $118.19 | 2019-2020 | |
| Chiesi USA, INC. | $115.45 | 2019-2025 | Kengreal |
| Scpharmaceuticals INC. | $101.91 | 2025 | |
| Actelion Pharmaceuticals US, INC. | $96.00 | 2024 | Uptravi, Opsumit |
| Penumbra, INC. | $95.78 | 2022 | |
| Lexicon Pharmaceuticals, INC. | $92.77 | 2023-2024 | Inpefa |
| Teleflex LLC | $87.27 | 2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $86.53 | 2025 | |
| Kiniksa Pharmaceuticals International, Plc | $53.97 | 2024 | Arcalyst |
| Heartflow, INC. | $36.37 | 2020-2023 | Ffrct |
| Impulse Dynamics (USA) INC. | $26.39 | 2023 | Optimizer |
| Stryker Corporation | $25.96 | 2025 | N/A |
| Inari Medical, INC. | $21.43 | 2023 | Flowtriever Catheter, S, Ct Thrombectomy System Kit |
| Cumberland Pharmaceuticals, INC. | $17.61 | 2025 | Caldolor |
| Regeneron Healthcare Solutions, INC. | $16.33 | 2019 | |
| Bioventus LLC | $15.75 | 2019 | |
| Baxter Healthcare | $15.35 | 2025 | Hillrom - Carnation Ambulatory Monitor |
| Cordis US Corp. | $14.96 | 2024 | Mynxgrip |
| Lundbeck LLC | $13.60 | 2019 | |
| Astellas Pharma US INC | $11.50 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Syed Ali listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.